The Centers for Medicare & Medicaid Services (CMS ) will lower the planned price of Medicare provider data under a final rule issued today, after the regional groups that wanted the data to create quality reports complained that previously proposed prices would keep them from participating.
The final rule implements a program—authorized by the Patient Protection and Affordable Care Act—that allows qualified organizations to access patient-protected Medicare data and produce public reports on physicians, hospitals and other healthcare providers.
Such reports, according to the agency, would combine Medicare claims data with private-sector claims data to identify the physicians and hospitals that provide the highest quality, most cost-effective care to patients.
The changes in the final rule from the original rule proposed in June included a requirement that the provider data cost less than originally proposed for qualified entities.
Under the earlier proposed version, data for 2.5 million beneficiaries would have cost $200,000. The final design would lower the costs for the same number of beneficiaries to $40,000 for the first year and $32,000 for each subsequent year.
Source: Modern Healthcare
Nomogram Predicts Overall Survival in Patients With Ovarian Cancer, Liver Metastases
January 9th 2025Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian cancer and liver metastases (OCLM), outperforming an external model in stability and accuracy.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More